ClearPoint Neuro (CLPT) Operating Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,579.00 |
| Dec 31, 2025 | -672.00 |
| Sep 30, 2025 | -2,340.00 |
| Jun 30, 2025 | -211.00 |
| Mar 31, 2025 | -3,383.00 |
| Dec 31, 2024 | -9,142.00 |
| Sep 30, 2024 | -3,240.00 |
| Jun 30, 2024 | -1,051.00 |
| Mar 31, 2024 | -1,587.00 |
| Dec 31, 2023 | -2,610.00 |
| Sep 30, 2023 | -1,824.00 |
| Jun 30, 2023 | -2,048.00 |
| Mar 31, 2023 | -1,723.00 |
| Sep 30, 2021 | 2,260.00 |
| Jun 30, 2021 | 9,286.00 |
| Mar 31, 2021 | 8,744.00 |
| Sep 30, 2020 | 12,320.00 |
| Jun 30, 2020 | 911,203.00 |
| Mar 31, 2020 | 26,265.00 |
| Dec 31, 2019 | 721,053.00 |
| Sep 30, 2019 | 41,393.00 |
| Jun 30, 2019 | 14,229.00 |
| Mar 31, 2019 | -30,582.00 |
| Dec 31, 2018 | -12,041.00 |
| Sep 30, 2018 | 649,192.00 |
| Jun 30, 2018 | 33,859.00 |
| Mar 31, 2018 | 80,008.00 |
| Sep 30, 2016 | 1,811.00 |
| Jun 30, 2016 | 182,694.00 |
| Mar 31, 2016 | 7,842.00 |